Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysozyme activities of skin granulomas of 24 patients in
leprosy
were studied. Lepra cells of all 15 lepromatous
leprosy
showed strong
lysozyme
activity in cytoplasma. In the specimens stained with
lysozyme
and Ziehl-Neelsen's carbolfuchsin double stain conspicuous
lysozyme
activity around M. leprae were observed. One borderline case was negative. Lysozyme of epithelioid cells and giant cells of 10 tuberculoid types were completely negative. These results suggest that
lysozyme
plays only a small role in the disposal of M. leprae in macrophages and other mechanisms than bacteriolytic function of
lysozyme
are responsible for the defence against these bacilli.
...
PMID:Immunohistochemical observation of lysozyme in macrophages in leprosy. 36 53
Serum amyloid protein (SAA) appears to be the precursor of amyloid protein AA, the non-immunoglobulin fibril protein of secondary amyloidosis. Since amyloidosis is known to occur in high frequency associated with lepromatous
leprosy
(LL), we have examined the SAA levels in untreated LL patients and compared them to the levels observed in patients with tuberculoid
leprosy
(TT) and a large number observed in healthy controls. We found that SAA is markedly elevated in LL when compared to TT and controls. No clear correlation could be established with C-reactive protein, a well-documented acute phase reactant, or serum
lysozyme
levels that reflect the presence of monocyte activity. This study showed that SAA levels in
leprosy
do not appear to be a reflection of inflammatory activity or monocyte turnover. Whether amyloidosis will be more prevalent in patients who have higher SAA levels remains to be determined.
...
PMID:Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy. 57 49
Mean serum
lysozyme
values were found to be elevated in untreated
leprosy
patients. Statistically significant elevations were present in each of the three major categories of
leprosy
, tuberculoid, borderline, and lepromatous. Values were particularly high in patients with severe reversal reactions or Lucio's phenomenon. Prolonged sulfone therapy was associated with a fall in serum
lysozyme
values. With an immunoperoxidase method to localize
lysozyme
in leprous tissues, two distinct staining patterns were found, granular and saccular. The grandular pattern of lysozymal staining was found in epithelioid cells and in giant cells, and the intensity of staining showed a positive correlation with serum
lysozyme
levels. Conversely, a saccular pattern of lysozymal staining was found in lepromatous histiocytes, buth the intensity of staining was unrelated to serum
lysozyme
levels; the saccular structures contained dense aggregates of Mycobacterium leprae. These two patterns of staining probably represent different functional responses of monocyte-derived granuloma cells, whereas the serum levels reflect, to a varying degree, both the absolute number of such cells and the rate of secretory activity of this cell population as a whole.
...
PMID:Serum and tissue lysozyme in leprosy. 59 Oct 69
We report on the histologic changes occurring in single cutaneous lesions, from six active lepromatous patients, 1 week following the administration of three daily intradermal injections, 35 micrograms each, of recombinant interferon gamma (rIFN-gamma). Except for a strong induration at the injection site, rIFN-gamma produced no adverse systemic reactions and was able to promote a remarkable influx of T-lymphocytes, mononuclear phagocytes with large nuclei, nonvacuolated cytoplasm, and reduced
lysozyme
reactivity. Furthermore, despite no clear-cut reduction of mycobacterial dermal burden, bacilli showed a clear increase in the granular appearance. Present findings provide a basis for further elucidation of rIFN-gamma as an additional tool for
leprosy
treatment.
...
PMID:Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changes. 142 37
Active tuberculosis (TB) and
leprosy
are difficult to diagnose early because there are few organisms to detect and the specific immune response does not distinguish between active and inactive disease. We developed an immunoassay for
lysozyme
to see whether serum
lysozyme
levels could be used to identify individuals with clinical
leprosy
or TB. The immunoassay for
lysozyme
proved superior to standard enzyme assays that were less sensitive and reliable. The
lysozyme
assay was compared with assays for antibodies to Mycobacterium tuberculosis lipoarabinomannan (LAM) and M. leprae phenolic glycolipid-1. The sera tested were from Ethiopian
leprosy
(paucibacillary and multibacillary) and TB patients and from healthy Ethiopian and U.S. controls. The
lysozyme
assay was able to detect more of the individuals with TB (sensitivity, 100% for 19 patients) or
leprosy
(sensitivity, 86% for 36 patients) than either antibody assay. In particular,
lysozyme
levels were raised in a higher proportion of the paucibacillary
leprosy
patients (83% of 17), for whom the antibody assays were less sensitive; the LAM IgG and the phenolic glycolipid-1 IgM levels were raised in only 62 and 44% of 16 patients, respectively. The data suggest that
lysozyme
measurements may be useful in the diagnosis of mycobacterial infections and other chronic infectious granulomatoses.
...
PMID:Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis. 158 6
A nocardioform bacterium was isolated from the spleen tissue of an armadillo infected with M. leprae and easily propagated in pure culture in mineral salt medium supplemented with only simple C and N sources (e.g., liquid paraffin, tetradecane, ammonium salts, urea, asparagine, gelatin, xanthin, hypoxanthin etc.). Complex organic substances, e.g., tyrosin, casein, peptone, meat extract, egg proteins, serum, blood, yeast extract as well as medium 199, did not support the growth of this organism. Microscopically, the organism consisted of acid-fast, long, slender rods which originated from long, fragmented hyphae, or sporulating mycelial tufts; it was acid-fast (at less than 4.0% H2SO4) which was pyridine-susceptible. It produced DOPA-oxidase and Catalase and was
lysozyme
resistant; this grew best under reduced O2 tension, at pH 7.0 to 8.0 and 28 degrees C. Serologically, it appeared to be only weakly related to the prototype human multibacillary
leprosy
-derived (reference) nocardioform strain, Nocardia brasiliensis and N. caviae, but was variably related to several mycobacteria strains.
...
PMID:Cultivation of a nocardioform acid-fast chemoautotrophic bacterium from armadillo tissues infected with Mycobacterium leprae. 218 9
Immunohistochemical staining of tuberculoid and lepromatous
leprosy
skin lesions was performed using various rabbit antisera. Macrophages in both stained with serum containing antibodies against
lysozyme
and alpha-1-antitrypsin, while macrophages in lepromatous
leprosy
also reacted with other antibodies. An immunoglobulin fraction of positive serum stained following pepsin digestion, indicating that reactivity was not Fc dependent. Positive serum contained antibody against Mycobacterium butyricum, which caused macrophage staining, since affinity-purified antibody did not stain and absorption with M. butyricum removed staining. Staining was also produced by serum of subjects with
leprosy
or a positive tuberculin test. By immunoblotting, the anti-mycobacterial antibody was directed against surface components of M. butyricum of molecular weights 20 000-70 000. Electron microscopy showed M. leprae in phagolysosomes of macrophages, while immunoelectron microscopy demonstrated labelling along bacterial cell membranes. Therefore, macrophages in lepromatous
leprosy
skin lesions stain because they contain M. leprae, which reacts with antibody to either M. leprae, M. tuberculosis or atypical mycobacteria in human serum and with antibody to M. butyricum in serum from rabbits immunized with various antigens and Freund's complete adjuvant. These results indicate that immunohistochemical studies on
leprosy
are misleading if performed using intact polyclonal immune sera rather than affinity purified or monoclonal antibodies.
...
PMID:Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera. 390 21
The levels and distribution of
lysozyme
-positive cells and exudate were studied in
leprosy
lesions through the spectrum, in untreated and treated patients, in relapse and in reactions. Altogether 124 skin biopsies were examined by the immunoperoxidase technique. Monocytes, neutrophil-polymorphs and mast cells were the most conspicuous cells seen. Lysozyme proved to be a useful means of indexing renewal of these cells in the lesions. Peak numbers of monocytes were seen in lesions of active lepromatous
leprosy
(LL) and of tuberculoid
leprosy
(TT), at poles of opposite immunological performance. In TT the stimulus for recruitment was delayed hypersensitivity (DH). A decline in DH from TT towards the middle of the spectrum, mid-borderline, was accompanied by a fall in monocyte level. Furthermore, reacting lesions due to enhanced DH also had increased numbers of monocytes. On the other hand reactions associated with immunological deterioration were similar to active lepromatous
leprosy
(LL) and monocyte influx was raised in response to the stimulus of free multiplication of bacilli in both cases. In TT delayed hypersensitivity acted also to promote the rapid transformation of monocytes to epithelioid and giant cells all of which were strongly positive for
lysozyme
. This was in contrast to much lower levels in histologically similar macrophage-epithelioid cells of BT granulomas. Lysozyme synthesis was not seen in macrophages after ingestion of M. leprae. Early foamy change was made conspicuous by
lysozyme
deposited in phagocytic vacuoles, but old foam cells in regressing lepromas were negative. Lysozyme bound to dead extracellular M. leprae but not to viable or intracellular organisms. Dead bacilli or immune complexes appeared to be the stimulus for neutrophil-polymorph recruitment, mainly in reactions.
...
PMID:Lysozyme as a measure of cellular dynamics in the lesions of leprosy. 397 Aug 26
Using the immunoperoxidase staining method, tissue
muramidase
(
lysozyme
) activity was studied in 34 nerve biopsies from
leprosy
patients and compared to findings in the skin. In a majority of lepromatous and borderline-lepromatous
leprosy
patients, the enzyme was seen to form a saccular pattern within the cells; whereas a granular pattern was found at the tuberculoid end of the
leprosy
spectrum, as well as during reversal reactions. Indeed, the most intense enzymatic activity was found in four patients with reversal reactions. Compared to the skin,
muramidase
activity was found to be more intense and persisted longer in the nerves. Successful antileprosy treatment reduced the enzymatic activity in both the nerves and the skin, but more so in the skin. Schwann cells and axons did not show
muramidase
activity, indicating that the
muramidase
-positive cells are not of neuronal origin. Our results suggest that a high percentage of mononuclear cells infiltrating the peripheral nerves in
leprosy
are derived from blood monocytes. The function of tissue
muramidase
in
leprosy
is not yet clear. Its peculiar intracellular distribution pattern in the different forms of
leprosy
, however, warrants further study to elucidate its role in the pathogenesis of the disease.
...
PMID:Muramidase (lysozyme) findings in sural and radial nerve biopsies in leprosy patients after varying periods of treatment. 402 Feb 11
A study has been made on mycobacterial-induced granulomas in guinea-pig lymph nodes. Lysozyme and angiotensin-converting enzyme (ACE) were measured in the auricular lymph nodes and serum of guinea-pigs which had received live BCG (Pasteur) or Cobalt (Co)-irradiated armadillo-derived Mycobacterium leprae intradermally into the ear or dinitrofluorobenzene (DNFB) painted epicutaneously upon the ears. In the lymph nodes with granulomas induced by either live BCG or killed M. leprae, the mean concentrations of
lysozyme
and ACE varied directly with the mean weight of the lymph nodes but the temporal pattern of weight change differed with the two agents. In M. leprae recipients at the time of peak lymph node weight, serum
lysozyme
and ACE values were significantly greater than those observed in controls; in animals receiving live BCG (Pasteur), serum
lysozyme
but not ACE values were elevated significantly at the time of peak lymph node weight. Four days following the epicutaneous application of DNFB, where there was no granuloma, there was a similar increase in the concentration of
lysozyme
and ACE in the lymph nodes. At the same time, there was also significant elevation in the serum
lysozyme
and ACE concentrations. Thus, in the granulomatous responses, the parallel tissue and serum changes in
lysozyme
and ACE concentrations were consistent with increased production and secretion of each enzyme by cells of the mononuclear phagocyte series. The increased
lysozyme
and ACE concentrations found in the lymph nodes of DNFB sensitised animals gives further evidence that such changes are not unique to granulomas. Finally, the intradermal administration of dead M. leprae in guinea pigs also produced increased
lysozyme
and ACE levels similar to that found in
leprosy
in man.
...
PMID:Lysozyme and angiotensin converting enzyme levels in experimental mycobacterial granulomas. 629 93
1
2
3
Next >>